Synovics Pharmaceuticals, Inc. (SYVC)

[Vigo]

Last interim CEO: Gerald Price

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=6936899

Who is?

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=6807799

Prior to joining us, Mr. Price served as Senior Vice President of Business Development for KV Pharmaceuticals from 2006 until 2009 where he was responsible for Global Development which encompassed both strategic and tactical endeavors including Product Selection, Product Prioritization, Supply Agreements, In-licensing and Out-licensing, and all M&A activities. From 2002 until 2006, prior to joining KV, Mr. Price was Vice President of Business Development for Ivax Corporation. From 2000 until 2002, Mr. Price held the post of President and Chief Operating Officer and was a member of the Board of Directors at Halsey Pharmaceuticals, a research company specializing in the development of controlled substance active ingredients and the accompanying dosage forms. Prior to that, Mr. Price enjoyed a successful 10 year career at Barr Laboratories. Initially hired as Corporate VP of Operations, Mr. Price also held the position of Executive VP of the Manufacturing Group which operated as a separate subsidiary. After five years of leading Operations at Barr, Mr. Price transitioned into Business Development as Vice President of Strategic Business Development for Barr with responsibilities for mergers and acquisitions, partnerships, and in-licensing. Before joining Barr, Mr. Price held a number of operations positions with larger OTC and consumer products companies. Mr. Price holds a BSIE degree for the University of Michigan and an MBA from the Siedman Business School.

.....

In connection with Mr. Price’s appointment, we have entered into an Independent Contractor Interim CEO Agreement pursuant to which Mr. Price is retained on a month-to-month basis as Interim Chief Executive Officer in consideration for $10,000 per month plus expense reimburse